Results 61 to 70 of about 22,412 (245)
Global haemostasis assays, from bench to bedside.
Item does not contain fulltextBleeding and thrombosis are the ultimate clinical outcomes of aberrations in the haemostatic process. Haemostasis prevents excessive blood loss due to the effort of various compartments like the vasculature, blood cells ...
Heerde, W.L. van, Geffen, M. van
core +1 more source
A Critical Review on the Evolution of Chitosan‐Based Injectable Hydrogels in Bone Regeneration
The graphical illustration depicts hydrogel formulation using chitosan and biocompatible cross‐linkers, major advantages, and incorporation of cells, osteoinductive factors, and therapeutic drugs. Following injection, pH‐responsive gelation enables controlled drug release, promotes cell recruitment and osteogenic differentiation, enhances extracellular
Shivani Santosh Sakhrani +2 more
wiley +1 more source
Background Haemophilia, caused by deficiencies in factor VIII or IX, leads to deep tissue bleeding and haemophilic arthropathy. Bleeding, arthropathy, and the perioperative period of surgery for arthropathy are associated with severe pain.
Yuya Mawarikado +13 more
doaj +1 more source
Discontinuation of Oral Antiplatelet Agents before Dental Extraction - Necessity or Myth?
Background: The risk of excessive bleeding often prompts physicians to interrupt the antiplatelet agents as acetylsalicilyc acid and clopidogrel before dental extractions which puts patients at risk of adverse thrombotic events.
Dinkova Atanaska S. +2 more
doaj +1 more source
A novel electrohydrodynamic platform integrating substrate‐independent in situ dried electrostretching (SI‐PIDES) and in situ focused electrospray deposition (IFED) enables mold‐free fabrication and precise drug coating of flexible core–sheath microneedle patches.
Ngoc Luan Mai +7 more
wiley +1 more source
Platelet Count Estimation using Unstained and Stained Peripheral Blood Smears: A Comparative Study [PDF]
Introduction: The manual count of platelets using stained smears is the most commonly employed method, although this method has its own limitations.
Suman Dhakar +4 more
doaj +1 more source
Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin +3 more
wiley +1 more source
Haemostatic Nanoparticles-Derived Bioactivity of from Selaginella tamariscina Carbonisata
High-temperature carbonisation is used to prepare many traditional Chinese medicine charcoal drugs, but the bioactive haemostatic substances of these medicines and their mechanisms are still unknown. This study developed and evaluated nanoparticles (NPs)
Yusheng Zhao +7 more
doaj +1 more source
Cell‐Based Biohybrid Micro/Nanorobots for Biotherapy
This review systematically evaluates cell‐based biohybrid micro/nanorobots (CB‐BMRs), highlighting their cell selection criteria, fabrication strategies, and diverse actuation modes. Furthermore, it surveys the promising therapeutic applications of CB‐BMRs in targeted cancer, thrombosis, and inflammation treatments, while comprehensively discussing ...
Lin Wang +11 more
wiley +1 more source
Background Recent advancements in haemophilia treatment have dramatically reduced the frequency of symptomatic bleeding. However, minor, asymptomatic bleeding may contribute to the progression of joint damage and decrease quality of life. Detecting small
Asuka Sakata +10 more
doaj +1 more source

